Header links

Institute
Research
Talent
Clinical trials
Innovation
Research support
Society

Francesca Imbastari

Institutions of which they are part

Administration and Management
Liver Diseases

Vall Hebron Institut de Recerca

Francesca Imbastari

Francesca Imbastari

Francesca Imbastari

Institutions of which they are part

Administration and Management
Liver Diseases

Vall Hebron Institut de Recerca

Related news

Dr. Raul Herance

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

See more

Related professionals

Elisabet Miro Casas

Elisabet Miro Casas

Research technician
Cardiovascular Diseases
Read more

Edurne Ruiz Marti

Edurne Ruiz Marti

Infectious Diseases
Read more

Ariadna Campos Martorell

Ariadna Campos Martorell

Growth and Development
Read more

Marta Aguayo Álvarez

Marta Aguayo Álvarez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.